Psychotropic drug use in relation to psychiatric symptoms in community- living persons with Alzheimer's disease

T. P. Semla, D. Cohen, S. Freels, G. J. Paveza, J. W. Ashford, P. Gorelick, D. Luchins, C. Eisdorfer

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

We attempted to determine the relationship between psychiatric symptoms and psychotropic drug use in persons with Alzheimer's disease based on a multicenter patient registry of 671 community-living persons diagnosed with the disease by published criteria. Logistic regression was performed to determine which symptoms were associated psychotropic use after controlling for age, sex, and Mini-Mental Status Examination (MMSE) score. At least one psychotropic drug was reported by 31% of patients, and 66% had at least one psychiatric symptom. Antipsychotics were associated with a lower MMSE score (odds ratio=0.92, 95% confidence interval 0.88-0.97), emotional lability (OR=4.52, 95% CI 1.69-11.94), and hallucinations (OR=6.54, 95% CI 2.99- 14.26). Antidepressants were associated with depressive symptoms (OR=5.8, 95% CI 2.61-13.46), and benzodiazepines with a lower MMSE score (OR=0.93, 95% CI 0.90-0.97). Community-living persons with Alzheimer's disease are frequently prescribed psychotropic drugs; however, more than 50% of patients with a psychiatric symptom did not report taking one of these agents. This suggests that alternative therapies and no treatment are also prevalent.

Original languageEnglish
Pages (from-to)495-501
Number of pages7
JournalPharmacotherapy
Volume15
Issue number4
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Psychotropic Drugs
Psychiatry
Alzheimer Disease
Hallucinations
Complementary Therapies
Benzodiazepines
Antidepressive Agents
Antipsychotic Agents
Registries
Logistic Models
Odds Ratio
Confidence Intervals
Depression
Therapeutics

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Semla, T. P., Cohen, D., Freels, S., Paveza, G. J., Ashford, J. W., Gorelick, P., ... Eisdorfer, C. (1995). Psychotropic drug use in relation to psychiatric symptoms in community- living persons with Alzheimer's disease. Pharmacotherapy, 15(4), 495-501.

Psychotropic drug use in relation to psychiatric symptoms in community- living persons with Alzheimer's disease. / Semla, T. P.; Cohen, D.; Freels, S.; Paveza, G. J.; Ashford, J. W.; Gorelick, P.; Luchins, D.; Eisdorfer, C.

In: Pharmacotherapy, Vol. 15, No. 4, 01.01.1995, p. 495-501.

Research output: Contribution to journalArticle

Semla, TP, Cohen, D, Freels, S, Paveza, GJ, Ashford, JW, Gorelick, P, Luchins, D & Eisdorfer, C 1995, 'Psychotropic drug use in relation to psychiatric symptoms in community- living persons with Alzheimer's disease', Pharmacotherapy, vol. 15, no. 4, pp. 495-501.
Semla TP, Cohen D, Freels S, Paveza GJ, Ashford JW, Gorelick P et al. Psychotropic drug use in relation to psychiatric symptoms in community- living persons with Alzheimer's disease. Pharmacotherapy. 1995 Jan 1;15(4):495-501.
Semla, T. P. ; Cohen, D. ; Freels, S. ; Paveza, G. J. ; Ashford, J. W. ; Gorelick, P. ; Luchins, D. ; Eisdorfer, C. / Psychotropic drug use in relation to psychiatric symptoms in community- living persons with Alzheimer's disease. In: Pharmacotherapy. 1995 ; Vol. 15, No. 4. pp. 495-501.
@article{cb70eadc9ade4c72b75641f57057268e,
title = "Psychotropic drug use in relation to psychiatric symptoms in community- living persons with Alzheimer's disease",
abstract = "We attempted to determine the relationship between psychiatric symptoms and psychotropic drug use in persons with Alzheimer's disease based on a multicenter patient registry of 671 community-living persons diagnosed with the disease by published criteria. Logistic regression was performed to determine which symptoms were associated psychotropic use after controlling for age, sex, and Mini-Mental Status Examination (MMSE) score. At least one psychotropic drug was reported by 31{\%} of patients, and 66{\%} had at least one psychiatric symptom. Antipsychotics were associated with a lower MMSE score (odds ratio=0.92, 95{\%} confidence interval 0.88-0.97), emotional lability (OR=4.52, 95{\%} CI 1.69-11.94), and hallucinations (OR=6.54, 95{\%} CI 2.99- 14.26). Antidepressants were associated with depressive symptoms (OR=5.8, 95{\%} CI 2.61-13.46), and benzodiazepines with a lower MMSE score (OR=0.93, 95{\%} CI 0.90-0.97). Community-living persons with Alzheimer's disease are frequently prescribed psychotropic drugs; however, more than 50{\%} of patients with a psychiatric symptom did not report taking one of these agents. This suggests that alternative therapies and no treatment are also prevalent.",
author = "Semla, {T. P.} and D. Cohen and S. Freels and Paveza, {G. J.} and Ashford, {J. W.} and P. Gorelick and D. Luchins and C. Eisdorfer",
year = "1995",
month = "1",
day = "1",
language = "English",
volume = "15",
pages = "495--501",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Psychotropic drug use in relation to psychiatric symptoms in community- living persons with Alzheimer's disease

AU - Semla, T. P.

AU - Cohen, D.

AU - Freels, S.

AU - Paveza, G. J.

AU - Ashford, J. W.

AU - Gorelick, P.

AU - Luchins, D.

AU - Eisdorfer, C.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - We attempted to determine the relationship between psychiatric symptoms and psychotropic drug use in persons with Alzheimer's disease based on a multicenter patient registry of 671 community-living persons diagnosed with the disease by published criteria. Logistic regression was performed to determine which symptoms were associated psychotropic use after controlling for age, sex, and Mini-Mental Status Examination (MMSE) score. At least one psychotropic drug was reported by 31% of patients, and 66% had at least one psychiatric symptom. Antipsychotics were associated with a lower MMSE score (odds ratio=0.92, 95% confidence interval 0.88-0.97), emotional lability (OR=4.52, 95% CI 1.69-11.94), and hallucinations (OR=6.54, 95% CI 2.99- 14.26). Antidepressants were associated with depressive symptoms (OR=5.8, 95% CI 2.61-13.46), and benzodiazepines with a lower MMSE score (OR=0.93, 95% CI 0.90-0.97). Community-living persons with Alzheimer's disease are frequently prescribed psychotropic drugs; however, more than 50% of patients with a psychiatric symptom did not report taking one of these agents. This suggests that alternative therapies and no treatment are also prevalent.

AB - We attempted to determine the relationship between psychiatric symptoms and psychotropic drug use in persons with Alzheimer's disease based on a multicenter patient registry of 671 community-living persons diagnosed with the disease by published criteria. Logistic regression was performed to determine which symptoms were associated psychotropic use after controlling for age, sex, and Mini-Mental Status Examination (MMSE) score. At least one psychotropic drug was reported by 31% of patients, and 66% had at least one psychiatric symptom. Antipsychotics were associated with a lower MMSE score (odds ratio=0.92, 95% confidence interval 0.88-0.97), emotional lability (OR=4.52, 95% CI 1.69-11.94), and hallucinations (OR=6.54, 95% CI 2.99- 14.26). Antidepressants were associated with depressive symptoms (OR=5.8, 95% CI 2.61-13.46), and benzodiazepines with a lower MMSE score (OR=0.93, 95% CI 0.90-0.97). Community-living persons with Alzheimer's disease are frequently prescribed psychotropic drugs; however, more than 50% of patients with a psychiatric symptom did not report taking one of these agents. This suggests that alternative therapies and no treatment are also prevalent.

UR - http://www.scopus.com/inward/record.url?scp=0029024014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029024014&partnerID=8YFLogxK

M3 - Article

C2 - 7479203

AN - SCOPUS:0029024014

VL - 15

SP - 495

EP - 501

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 4

ER -